Pharma Focus Asia

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Porton Advanced Launches MaxCyte ExPERT GTx Flow Electroporation System to Enhance Cell and Gene Therapy Offerings

Wednesday, June 26, 2024

Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China

Junshi Biosciences Receives Approval for Toripalimab as a First-Line Therapy for Advanced Triple-Negative Breast Cancer

Wednesday, June 26, 2024

Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration

Lilly and OpenAI Collaborate on Developing New Treatments for Drug-Resistant Bacteria

Wednesday, June 26, 2024

Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance

GSK's Omjjara (Momelotinib) Receives Approval in Japan for Treating Myelofibrosis

Tuesday, June 25, 2024

GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type

SK Bioscience and Sanofi Receive IND Approval for Phase 3 Global Clinical Trial of Next-Generation Pneumococcal Vaccine

Tuesday, June 25, 2024

SK Bioscience and Sanofi have reached a significant milestone with the approval of the global Phase clinical trial plan for their valent pneumococcal conjugate vaccine candidate GBP

ANI Pharmaceuticals Plans to Expand Its Rare Disease Business by Acquiring Alimera Sciences

Tuesday, June 25, 2024

ANI Pharmaceuticals Inc and Alimera Sciences Inc have announced a definitive agreement where ANI will acquire Alimera for per share in cash at closing along with a contingent value right

Biond Biologics Begins Phase 1 Clinical Trial, Administers First Dose of BND-35

Tuesday, June 25, 2024

Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient...

ILiAD Biotechnologies Plans Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, for Phase III Clinical Trials of BPZE1, a Next-Generation Pertussis Vaccine

Tuesday, June 25, 2024

ILiAD Biotechnologies LLC a biotechnology company focused on combating diseases caused by Bordetella

AstriVax Begins Clinical Trials for Innovative Vaccine Platform Technology

Monday, June 24, 2024

AstriVax has commenced a Phase I clinical study to assess the safety and effectiveness of its prophylactic vaccines for yellow fever and rabies in healthy adults This initial human trial called SAFYR aims to provide essential safety and immunogenicit...

Roche Introduces Advanced Analytical Units for cobas® pro Integrated Solutions, Boosting Laboratory Efficiency and Capacity

Monday, June 24, 2024

Roche has announced the launch of its latest analytical units the cobas c and cobas ISE neo under the cobas pro integrated solutions now available in countries that accept the CE mark

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024